Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Key Takeaways Adding 2mL of bacteriostatic water to a 5mg BPC-157 vial produces a 2,500 mcg/mL concentration, the most practical starting point for accurate subcutaneous dosing on a U-100 syringe
For coronary artery disease, where partial blockages reduce blood flow to heart muscle, enhanced collateral development could improve myocardial perfusion
References Nature Medicine (2014) Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity PMC (2024) Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions Frontiers in Pharmacology (2024) NNMT: a novel therapeutic target for metabolic syndrome PubMed (2021) LC-MS/MS assay for 5-amino-1-methylquinolinium: pharmacokinetic and oral bioavailability study ResearchGate (2021) Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice PMC (2022) Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice NMN.com / Scientific Reports Role of NNMT inhibition in muscle strength: enhanced grip strength with exercise Swolverine 5-Amino-1MQ mechanism, benefits, stacking and cycling guide PMC Subcutaneous drug injection review: pharmacologic considerations CDC Vaccine administration: subcutaneous route (angle/site
Book an appointment and take the first step toward better health
BPC-157 is a research compound derived from gastric protective protein, not FDA or EMA approved for therapeutic indications
FBN merchandise provided in recognition of testimonials.
US$ 26.18
US$ 20.53
US$ 29.80
US$ 25.10
US$ 25.57
US$ 26.29
US$ 21.12
